Dr Tony Simula was previously Manager, Development & Commercialisation at the Cooperative Research Centre for Cell Therapy Manufacturing (CTM CRC), where he oversaw the transition of technologies from the proof-of-concept stage through to pilot-scale, adding value prior to their commercialisation. Dr Simula has worked in private and public sector research organisations, including two previous Cooperative Research Centres, and publicly listed Australian and European companies of varying sizes. He has 10 years’ international academic research experience, followed by 20 years in the commercial biopharmaceutical/cell therapy industry.

Dr Sue Low is Operations Manager at TekCyte and oversees the daily activities at the company’s cleanroom facility and laboratories. With a background in biomaterials development, Dr Low received her PhD on dissolvable ocular biomaterials in 2008. After, Dr Low worked in a similar field, but with a focus on plasma surface modification to improve biomaterial compatibility. With an interest in the downstream processes of medical device development, Dr Low also began training to work under GMP cleanroom conditions. This involved creation of a new Quality System for the TekCyte facility and maintaining a cleanroom facility to GMP requirements.

Dr Louise Smith is responsible for translating laboratory scale research to commercial scale. Louise received her PhD in 2008 from the University of Sheffield in biomaterials for wound healing. She continued developing biomaterials for wound healing applications after completing her PhD, work that brought her to Australia in 2011. In 2013 she became a project leader for the Cooperative Research Centre for Cell Therapy Manufacturing (CTM CRC), leading a team that developed a dressing to deliver mesenchymal stromal cells to wounds. The challenges involved in scaling up technology from the academic environment to commercial scale led to her joining TekCyte in 2017.

Dr Eli Moore, PhD, is an expert in biomaterials for cardiovascular applications at the Centre for Cancer Biology in Adelaide. Eli is an experienced researcher with a demonstrated history of working in the hospital and healthcare industry. He is a strong research professional with a Doctor of Philosophy (PhD) focused in Nanotechnology from University of South Australia.

His research on nano-polymer films includes improving the biocompatibility of blood-contacting medical devices that resulted in the invention and patents covering BIOINVISIBLE™.

Dr Sameer Al-Bataineh is a Senior Materials Engineer at TekCyte with a strong background in surface engineering and characterisation of biomaterials. He joined TekCyte in 2020, after 14 years of international and national academic research experiences in applied biomaterials research. Dr Al-Bataineh received his PhD from the University of South Australia in 2006. His PhD was on the development of antimicrobial coatings for biomaterials utilised in biomedical applications. Dr Al-Bataineh has advanced expertise in surface coatings, plasma polymerisation processes (both vacuum and atmospheric), plasma diagnostics, scale-up of coating processes, surface characterisation and data analysis. He also has a wide experience in managing research projects.

Tekcyte
Email Us
Enquiry Form
This field is for validation purposes and should be left unchanged.
Pop Img 1
Pop Bioinvisible
Discover more about our flagship product BIOINVISIBLE™
This field is for validation purposes and should be left unchanged.

Share This

Select your desired option below to share a direct link to this page.
Your friends or family will thank you later.

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on email